{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:58:29Z","timestamp":1778252309754,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,10,24]],"date-time":"2009-10-24T00:00:00Z","timestamp":1256342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s10620-009-1020-0","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T16:10:14Z","timestamp":1256314214000},"page":"631-641","source":"Crossref","is-referenced-by-count":31,"title":["Highly Purified Eicosapentaenoic Acid Ethyl Ester Prevents Development of Steatosis and Hepatic Fibrosis in Rats"],"prefix":"10.1007","volume":"55","author":[{"given":"Satoshi","family":"Kajikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Imada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,24]]},"reference":[{"key":"1020_CR1","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.3748\/wjg.v13.i34.4539","volume":"13","author":"M Duvnjak","year":"2007","unstructured":"Duvnjak M, Leroti\u0107 I, Bar\u0161i\u0107 N, Toma\u0161i\u0107 V, Virovi\u0107 Juki\u0107 L, Velagi\u0107 V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol. 2007;13:4539\u20134550.","journal-title":"World J Gastroenterol"},{"key":"1020_CR2","doi-asserted-by":"crossref","first-page":"1499S","DOI":"10.1093\/ajcn\/83.6.1499S","volume":"83","author":"YA Carpentier","year":"2006","unstructured":"Carpentier YA, Portois L, Malaisse WJ. n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr. 2006;83:1499S\u20131504S.","journal-title":"Am J Clin Nutr"},{"key":"1020_CR3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1172\/JCI118304","volume":"96","author":"KS Lee","year":"1995","unstructured":"Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF\u03b1 and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest. 1995;96:2461\u20132468.","journal-title":"J Clin Invest"},{"key":"1020_CR4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2004.01888.x","volume":"19","author":"A Uygun","year":"2004","unstructured":"Uygun A, Kadayifci A, Isik AT, et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2004;19:537\u2013544.","journal-title":"Aliment Pharmacol Ther"},{"key":"1020_CR5","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","volume":"355","author":"R Belfort","year":"2006","unstructured":"Belfort R, Harrison SA, Brown K, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 2006;355:2297\u20132307.","journal-title":"N Engl J Med"},{"key":"1020_CR6","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.amjgastroenterol.2003.08.001","volume":"98","author":"LA Adams","year":"2003","unstructured":"Adams LA, Angulo P. Vitamins E and C for the treatment of NASH: Duplication of results but lack of demonstration of efficacy. Am J Gastroenterol. 2003;98:2348\u20132350.","journal-title":"Am J Gastroenterol"},{"key":"1020_CR7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1872-034X.2008.00363.x","volume":"38","author":"S Nakano","year":"2008","unstructured":"Nakano S, Nagasawa T, Ijiro T, et al. Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-\u03b21 in a cultured stellate cell line. Hepatol Res. 2008;38:1026\u20131039.","journal-title":"Hepatol Res"},{"key":"1020_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2005.08.002","volume":"17","author":"YB Lombardo","year":"2006","unstructured":"Lombardo YB, Chicco AG. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem. 2006;17:1\u201313.","journal-title":"J Nutr Biochem"},{"key":"1020_CR9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","volume":"40","author":"L Spadaro","year":"2008","unstructured":"Spadaro L, Magliocco O, Spampinato D, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis. 2008;40:194\u2013199.","journal-title":"Dig Liver Dis"},{"key":"1020_CR10","first-page":"1","volume":"2","author":"T Kurihara","year":"1999","unstructured":"Kurihara T, Akimoto M, Ishiguro H, et al. Effects of eicosapentaenoic acid on blood rheology in hyperlipidemic fatty liver patients. Hemorheol Relat Res. 1999;2:1\u20137.","journal-title":"Hemorheol Relat Res"},{"key":"1020_CR11","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","volume":"369","author":"M Yokoyama","year":"2007","unstructured":"Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090\u20131098.","journal-title":"Lancet"},{"key":"1020_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.plefa.2009.02.004","volume":"80","author":"S Kajikawa","year":"2009","unstructured":"Kajikawa S, Harada T, Kawashima A, Imada K, Mizuguchi K. Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat\/high-sucrose diet-fed mice. Prostaglandins Leukot Essent Fatty Acids. 2009;80:229\u2013238.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1020_CR13","doi-asserted-by":"crossref","first-page":"G865","DOI":"10.1152\/ajpgi.2001.281.4.G865","volume":"281","author":"SD Clarke","year":"2001","unstructured":"Clarke SD. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am J Physiol Gastrointest Liver Physiol. 2001;281:G865\u2013869.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1020_CR14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/BF02535573","volume":"27","author":"A Demoz","year":"1992","unstructured":"Demoz A, Willumsen N, Berge RK. Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids. 1992;27:968\u2013971.","journal-title":"Lipids"},{"key":"1020_CR15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbalip.2009.01.014","volume":"1791","author":"S Kajikawa","year":"2009","unstructured":"Kajikawa S, Harada T, Kawashima A, Imada K, Mizuguchi K. Suppression of hepatic fat accumulation by highly purified eicosapentaenoic acid prevents the progression of d-galactosamine-induced hepatitis in mice fed with a high-fat\/high-sucrose diet. Biochim Biophys Acta. 2009;1791:281\u2013288.","journal-title":"Biochim Biophys Acta"},{"key":"1020_CR16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/07315724.2004.10719345","volume":"23","author":"Y Zhao","year":"2004","unstructured":"Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-\u03b1 expression by preventing NF-\u03baB activation. J Am Coll Nutr. 2004;23:71\u201378.","journal-title":"J Am Coll Nutr"},{"key":"1020_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nut.2007.11.005","volume":"24","author":"S Sierra","year":"2008","unstructured":"Sierra S, Lara-Villoslada F, Comalada M, Olivares M, Xaus J. Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as decosahexaenoic acid but differ in inflammatory effects. Nutrition. 2008;24:245\u2013254.","journal-title":"Nutrition"},{"key":"1020_CR18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0016-5085(96)70028-8","volume":"111","author":"MD Weltman","year":"1996","unstructured":"Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology. 1996;111:1645\u20131653.","journal-title":"Gastroenterology"},{"key":"1020_CR19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1006811009809","volume":"188","author":"S Takeo","year":"1998","unstructured":"Takeo S, Nasa Y, Tanonaka K, et al. Effects of long-term treatment with eicosapentaenoic acid on the heart subjected to ischemia\/reperfusion and hypoxia\/reoxygenation in rats. Mol Cell Biochem. 1998;188:199\u2013208.","journal-title":"Mol Cell Biochem"},{"key":"1020_CR20","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1161\/ATVBAHA.108.171736","volume":"28","author":"H Yamada","year":"2008","unstructured":"Yamada H, Yoshida M, Nakano Y, et al. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 2008;28:2173\u20132179.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1020_CR21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497\u2013509.","journal-title":"J Biol Chem"},{"key":"1020_CR22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0003-9861(61)90291-0","volume":"93","author":"JF Woessner Jr","year":"1961","unstructured":"Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961;93:440\u2013447.","journal-title":"Arch Biochem Biophys"},{"key":"1020_CR23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","volume":"34","author":"H Yoshiji","year":"2001","unstructured":"Yoshiji H, Kuriyama S, Yoshii J, et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology. 2001;34:745\u2013750.","journal-title":"Hepatology"},{"key":"1020_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","volume":"364","author":"S Tsukada","year":"2006","unstructured":"Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta. 2006;364:33\u201360.","journal-title":"Clin Chim Acta"},{"key":"1020_CR25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","volume":"44","author":"JW Haukeland","year":"2006","unstructured":"Haukeland JW, Dam\u00e5s JK, Konopski Z, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol. 2006;44:1167\u20131174.","journal-title":"J Hepatol"},{"key":"1020_CR26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(02)00331-8","volume":"38","author":"Y Sumida","year":"2003","unstructured":"Sumida Y, Nakashima T, Yoh T, et al. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol. 2003;38:32\u201338.","journal-title":"J Hepatol"},{"key":"1020_CR27","doi-asserted-by":"crossref","first-page":"298S","DOI":"10.1097\/01.alc.0000191810.46000.37","volume":"29","author":"K Tokushige","year":"2005","unstructured":"Tokushige K, Hashimoto E, Tsuchiya N, Kaneda H, Taniai M, Shiratori K. Clinical significance of soluble TNF receptor in Japanese patients with non-alcoholic steatohepatitis. Alcohol Clin Exp Res. 2005;29:298S\u2013303S.","journal-title":"Alcohol Clin Exp Res"},{"key":"1020_CR28","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/infdis\/167.6.1344","volume":"167","author":"L Shapiro","year":"1993","unstructured":"Shapiro L, Clark BD, Orencole SF, Poutsiaka DD, Granowitz EV, Dinarello CA. Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J Infect Dis. 1993;167:1344\u20131350.","journal-title":"J Infect Dis"},{"key":"1020_CR29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(03)00376-3","volume":"39","author":"J George","year":"2003","unstructured":"George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol. 2003;39:756\u2013764.","journal-title":"J Hepatol"},{"key":"1020_CR30","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1440-1746.2006.04701.x","volume":"22","author":"R Vetel\u00e4inen","year":"2007","unstructured":"Vetel\u00e4inen R, van Vliet A, van Gulik TM. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J Gastroenterol Hepatol. 2007;22:1526\u20131533.","journal-title":"J Gastroenterol Hepatol"},{"key":"1020_CR31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/01902148909087861","volume":"15","author":"JI Kennedy Jr","year":"1989","unstructured":"Kennedy JI Jr, Chandler DB, Fulmer JD, Wert MB, Grizzle WE. Dietary fish oil inhibits bleomycin-induced pulmonary fibrosis in the rat. Exp Lung Res. 1989;15:315\u2013329.","journal-title":"Exp Lung Res"},{"key":"1020_CR32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u2013218.","journal-title":"J Clin Invest"},{"key":"1020_CR33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.phrs.2008.05.002","volume":"57","author":"D Richard","year":"2008","unstructured":"Richard D, Kefi K, Barbe U, Bausero P, Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol Res. 2008;57:451\u2013455.","journal-title":"Pharmacol Res"},{"key":"1020_CR34","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3748\/wjg.14.2474","volume":"14","author":"TC Schreuder","year":"2008","unstructured":"Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol. 2008;14:2474\u20132486.","journal-title":"World J Gastroenterol"},{"key":"1020_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","volume":"6","author":"K Begriche","year":"2006","unstructured":"Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it. Mitochondrion. 2006;6:1\u201328.","journal-title":"Mitochondrion"},{"key":"1020_CR36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/003655298750026561","volume":"228","author":"I Kovalszky","year":"1998","unstructured":"Kovalszky I, Nagy P, Szende B, et al. Experimental and human liver fibrogenesis. Scand J Gastroenterol Suppl. 1998;228:51\u201355.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"1020_CR37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-230X-3-29","volume":"3","author":"M Arias","year":"2003","unstructured":"Arias M, Sauer-Lehnen S, Treptau J, et al. Adenoviral expression of a transforming growth factor-\u03b21 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol. 2003;3:29.","journal-title":"BMC Gastroenterol"},{"key":"1020_CR38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/jhep.2000.9109","volume":"32","author":"T Nakamura","year":"2000","unstructured":"Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor \u03b2 prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology. 2000;32:247\u2013255.","journal-title":"Hepatology"},{"key":"1020_CR39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/00004872-199917100-00009","volume":"17","author":"M Nakayama","year":"1999","unstructured":"Nakayama M, Fukuda N, Watanabe Y, et al. Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-\u03b2. J Hypertens. 1999;17:1421\u20131430.","journal-title":"J Hypertens"},{"key":"1020_CR40","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.metabol.2006.07.019","volume":"55","author":"M Zhang","year":"2006","unstructured":"Zhang M, Hagiwara S, Matsumoto M, et al. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKAy\/Ta mice: Involvement of anti-inflammation and antioxidative stress. Metabolism. 2006;55:1590\u20131598.","journal-title":"Metabolism"},{"key":"1020_CR41","first-page":"649","volume":"20","author":"B Desvergne","year":"1999","unstructured":"Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev. 1999;20:649\u2013688.","journal-title":"Endocr Rev"},{"key":"1020_CR42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/oby.2002.70","volume":"10","author":"C Chambrier","year":"2002","unstructured":"Chambrier C, Bastard JP, Rieusset J, et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor \u03b3. Obes Res. 2002;10:518\u2013525.","journal-title":"Obes Res"},{"key":"1020_CR43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.plefa.2008.07.002","volume":"1\u20132","author":"A Kawashima","year":"2008","unstructured":"Kawashima A, Harada T, Imada K, Yano T, Mizuguchi K. Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1\u03b2-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma. Prostaglandins Leukot Essent Fatty Acids. 2008;1\u20132:59\u201365.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1020_CR44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/00365520802530861","volume":"44","author":"YM Nan","year":"2009","unstructured":"Nan YM, Fu N, Wu WJ, et al. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Scand J Gastroenterol. 2009;44:358\u2013365.","journal-title":"Scand J Gastroenterol"},{"key":"1020_CR45","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","volume":"122","author":"A Galli","year":"2002","unstructured":"Galli A, Crabb DW, Ceni E, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology. 2002;122:1924\u20131940.","journal-title":"Gastroenterology"},{"key":"1020_CR46","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/00004872-199210000-00006","volume":"10","author":"R Hui","year":"1992","unstructured":"Hui R, Robillard M, Falardeau P. Inhibition of vasopressin-induced formation of diradylglycerols in vascular smooth muscle cells by incorporation of eicosapentaenoic acid in membrane phospholipids. J Hypertens. 1992;10:1145\u20131153.","journal-title":"J Hypertens"},{"key":"1020_CR47","doi-asserted-by":"crossref","first-page":"11167","DOI":"10.1074\/jbc.M211424200","volume":"278","author":"W Yu","year":"2003","unstructured":"Yu W, Murray NR, Weems C, et al. Role of cyclooxygenase 2 in protein kinase C \u03b2II-mediated colon carcinogenesis. J Biol Chem. 2003;278:11167\u201311174.","journal-title":"J Biol Chem"},{"key":"1020_CR48","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MCG.0b013e31815591aa","volume":"42","author":"N Tanaka","year":"2008","unstructured":"Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413\u2013418.","journal-title":"J Clin Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-1020-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-009-1020-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-1020-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T19:42:54Z","timestamp":1634067774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-009-1020-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,24]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1007\/s10620-009-1020-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,24]]}}}